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ABSTRACT  36 
 37 
Background & Aims 38 
Vitamin K acts as a coenzyme in the γ-carboxylation of vitamin K-dependent proteins, including 39 
coagulation factors, osteocalcin, matrix Gla protein (MGP), and the growth arrest-specific 6 40 
(GAS6) protein. Osteocalcin is a key factor for bone matrix formation. MGP is a local inhibitor of 41 
soft tissue calcification. GAS6 activity prevents the apoptosis of vascular smooth muscle cells. Few 42 
data on vitamin K intake in chronic kidney disease patients and no data in patients on a 43 
Mediterranean diet are available. In the present study, we evaluate the dietary intake of vitamin K1 44 
in a cohort of patients undergoing hemodialysis. 45 
Methods  46 
In this multi-center controlled observational study, data were collected from 91 patients aged > 18 47 
years on dialysis treatment for at least 12 months and from 85 age-matched control subjects with 48 
normal renal function. Participants completed a food journal of seven consecutive days for the 49 
estimation of dietary intakes of macro- and micro-nutrients (minerals and vitamins). 50 
Results  51 
Compared to controls, dialysis patients had a significant lower total energy intake, along with a 52 
lower dietary intake of proteins, fats, carbohydrates, fibres, and of all the examined minerals (Ca, P, 53 
Fe, Na, K, Zn, Cu, and Mg). With the exception of vitamin B12, vitamins intake followed a similar 54 
pattern, with a lower intake in vitamin A, B1, B2, C, D, E, folates, K1 and PP. These finding were 55 
confirmed also when normalized for total energy intake or for body weight. 56 
In respect to the adequate intakes recommended in the literature, the prevalence of a deficient 57 
vitamin K intake was very high (70% to 90%) and roughly double than in controls.  Multivariate 58 
logistic model identified Vitamin A and iron intake as predictors of vitamin K deficiency 59 
Conclusions.  60 
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Hemodialysis patients had a significantly low intake in vitamin K1, which could contribute to 61 
increase the risk of bone fractures and vascular calcifications. Since the deficiency of vitamin K 62 
intake seems to be remarkable, dietary counselling to HD patients should also address the adequacy 63 
of vitamin K dietary intake and bioavailability. Whether diets with higher amounts of vitamin K1 or 64 
vitamin K supplementation can improve clinical outcomes in dialysis patients remains to be 65 
demonstrated. 66 
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INTRODUCTION 70 
Vitamin K is a fat-soluble vitamin, which includes a series of vitamers: phylloquinones (vitamin 71 
K1) and menaquinones (vitamin K2). Vitamin K1 is found mainly in green leafy vegetables while 72 
vitamin K2 is mainly synthesized by intestinal bacteria and is found in butter and fermented cheeses 73 
[1]. 74 
Vitamin K1 is the main source of vitamin K. Vegetables in particular contain relevant amounts of 75 
phylloquinone, although there is great variability in vitamin K1 content among different vegetables. 76 
Green leafy vegetables and cabbages have the highest content and contribute to 40-50% of total 77 
intake [2] while most of fruits, fruit juices and other vegetables, such as carrots and tomatoes, have 78 
a lower content. Since Vitamin K1 is fat-soluble, its intestinal absorption is higher when introduced 79 
with vegetable oils, as soy, cottonseed, canola or olive oil. 80 
Compared to phylloquinone, the dietary contribution of menaquinones intake is markedly lower. 81 
Dietary sources of vitamin K2 are chicken, egg yolk, dairy products, fermented cheeses in 82 
particular, cow liver and natto, a Japanese food made from fermented soybeans, which has the 83 
highest vitamin K2 content. 84 
Some investigators also suggested the hypothesis of a conversion of dietary phylloquinone in 85 
menaquinone-4 (MK-4): it was reported that MK-4 is present in tissues of animals fed with 86 
phylloquinone as a sole source of vitamin K [3]. Extra-hepatic tissues from rats were shown to 87 
contain more MK-4 after phylloquinone administration rather than after MK-4 administration. High 88 
concentration of MK-4 were also found in extra-hepatic human tissues [4, 5]. 89 
Vitamin K acts as a coenzyme in the γ-carboxylation of vitamin K-dependent proteins (VKDPs), 90 
including coagulation factors, osteocalcin (bone Gla protein, BGP), matrix Gla protein (MGP), and 91 
the growth arrest-specific 6 (GAS6) protein. BGP is produced by osteoblasts during bone matrix 92 
formation and its hydroxyapatite-binding capacity is dependent on the vitamin K γ-carboxylation. 93 
MGP is produced by osteoclasts, chondrocytes and vascular smooth muscle cells and is a local 94 
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inhibitor of soft tissue calcification. The γ-carboxylation determines MGP bioactivity in preventing 95 
vascular calcification [6]. In this context, GAS6 activity is also relevant since it prevents the 96 
apoptosis of vascular smooth muscle cells [7]. 97 
Up to now, no evidence exists for an average requirement of Vitamin K, and as a consequence the 98 
Recommended Daily Allowance (RDA) is not defined. Hence, an Adequate Intake (AI) has been set 99 
based on representative dietary intake data from healthy subjects. In the U.S.A., the Food and 100 
Nutrition Board at the Institute of Medicine recommends an AI of 120 µg/day for men and 90 101 
µg/day for women [8].  Instead, the Italian Society of Human Nutrition recommends an AI of 140 102 
µg/day below 60 years of age and 170 µg/day above 60 years [9].  103 
When considering the AI for vitamin K, no distinction is made between the different forms. This 104 
can be justified by the fact that phylloquinone is the major form in the diet while menaquinones, 105 
collectively referred to as vitamin K2, contribute a relatively small amount to satisfying the human 106 
requirement for vitamin K. 107 
A deficit of vitamin K, due to a low dietary intake, potentially leads to a low serum level of 108 
carboxylated Gla proteins (VKDPs) and therefore to an increased risk of vascular calcification and 109 
bone fractures [10]. 110 
In chronic kidney disease, vascular calcification and mineral and bone disorders are very common: 111 
the risk of hip fracture is four times higher and that of aortic calcification is twice higher than in the 112 
general population [11, 12]. Recent studies have demonstrated that low levels of vitamin K are 113 
predictors of hip and vertebral fractures, aortic calcification, and cardiovascular disease [11, 13]. 114 
Growing evidence indicates that hemodialysis (HD) patients are at high risk of vitamin K 115 
deficiency. To achieve a lower dietary load of potassium and phosphorus, patients with end stage 116 
renal disease limit foods representing main sources of vitamin K, especially phylloquinone [14-16]. 117 
Regardless of its cause, vitamin K deficiency could worsen the fragile clinical status of this subset 118 
of patients in terms of cardiovascular disease and mineral bone disorders. Because data on vitamin 119 
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K intake in ESRD patients on a Mediterranean diet are lacking, in the present study we evaluate the 120 
dietary intake of vitamin K1 in a cohort of clinically stable patients undergoing maintenance HD. 121 
 122 
METHODS 123 
Participants 124 
This observational study, collecting information reflecting the usual clinical practice, is population 125 
based, multi-center and controlled. Demographics and clinical data were collected from the medical 126 
charts of patients aged > 18 years on HD treatment for at least 12 months. Exclusion criteria were: 127 
life expectancy lower than 6 months, a history or evidence of malignancy (except for non-128 
melanoma skin neoplasia), gastrointestinal diseases with malabsorption, liver insufficiency, acute 129 
infectious diseases, psychiatric illnesses, use of antibiotics in the week preceding the dietary 130 
questionnaire. Only 6 patients (7%) were using warfarin and they were not excluded. A control 131 
group was formed by people without chronic kidney diseases and comparable for age, gender and 132 
race; they were hospital employers, nurses, or patient’s partners. All the participants gave their own 133 
informed consent to the study, which did not modify the patient’s clinical management. The study is 134 
in accordance with the Helsinki Declaration. 135 
 136 
Dietary assessment 137 
With the aim of assessing the nutritional status, participants were asked to complete a food journal 138 
of seven consecutive days for the estimation of dietary intakes of macro- and micro-nutrients 139 
(minerals and vitamins) between 2013 and 2014. An individual food journal was given to each 140 
patient. An experienced operator provided all the necessary information for a correct compilation. 141 
The food journal reported a description of the type and amount of food and beverages consumed in 142 
the different meals or during all the days of the week. 143 
When completed, the diary was handed back to the operator who interviewed the patients with the 144 
aim to accurately verify the data reported in the diary, making any needed corrections or 145 
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integrations. The actual amount of food consumed was recorded by weighing or through the use of 146 
photographic images of real size portions included in the Atlas Photo Food by the Scotti-Bassani 147 
Institute [17]. 148 
The processing of data collected from the diaries allowed to estimate the average daily intake of 149 
Vitamin K1, using data on the content of vitamin K1 supplied by the United States Department of 150 
Agriculture (USDA), referring to over 900 foods including foods also typical of the Mediterranean 151 
diet [18]. 152 
We also estimated the energy and nutrients intake, namely protein, carbohydrates, lipids, 153 
unsaturated fatty acids, saturated fats, cholesterol, calcium, phosphorus, magnesium, iron, zinc, 154 
copper, fiber, and vitamins A, C, B1, B2, PP, D. Data were obtained using the food composition 155 
Tables of the Italian National Institute of Nutrition and of the European Institute of Oncology 156 
Database Edition 2008 [19, 20].The daily energy and nutrients intake were reported as daily average 157 
of the 7-day food records. When appropriate, intakes were normalized by body weight or energy 158 
intake. Adjustment for total energy intake is usually appropriate in epidemiologic studies to control 159 
for confounding, reduce extraneous variation, and predict the effect of dietary interventions [21]. 160 
 161 
Statistical analysis 162 
Data are expressed as mean ± standard deviation (SD), or median and inter-quartile range (Q1-Q3), 163 
for quantitative variables, and frequency percentages for discrete variables. Normal distribution of 164 
continuous variables was tested using the Shapiro-Wilk test. 165 
The differential distribution for categorical variables among HD patients and controls was analyzed 166 
considering the χ2 test or the Fisher’s exact test. Quantitative variables were compared among 167 
groups of subjects (HD patients vs controls) considering the Generalized Linear Model (GLM), 168 
after testing for homoschedasticity (Levene’s test) or the non-parametric Mann-Whitney test.  169 
Associations between variables measured in the study and low vitamin K intake were analyzed by 170 
univariate and multivariate regression. Variables associated with the low vitamin K intake were 171 
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identified using univariate logistic regression. Any significant predictors with p 0.10 were then 172 
introduced into a multivariate model using the stepwise selection method. Statistical significance 173 
was assumed for p-value<0.05. Analyses were carried out using SAS Software 9.3 (SAS Institute, 174 
Cary, NC, USA). 175 
 176 
RESULTS 177 
Ninety-one HD patients and 85 healthy controls, comparable for age and gender, were included in 178 
the analysis (Table 1). Some features of the studied HD patient group are reported in Table 1: weight 179 
and BMI were significantly lower in patients than in controls.  180 
Table 2 shows the daily dietary intakes of macronutrients, minerals and vitamins. HD patients 181 
showed a significant lower total energy intake with a lower dietary intake of proteins, fats, fibres 182 
and carbohydrates compared to controls. HD patients had significantly lower dietary intake for all 183 
the examined minerals (Ca, P, Fe, Na, K, Zn, Cu, and Mg) than healthy controls (Table 2). 184 
Vitamins intake followed a similar pattern, having HD patients significantly lower intake in vitamin 185 
A, B1, B2, C, D, E, folates, and PP, although no differences came to light for vitamin B12, as 186 
reported in Table 2.  As a whole, HD patients ate less than controls, according to a lower body 187 
mass. However, differences in energy and protein intake are attenuated, but not blunted, when 188 
expressed as normalized by body weight (Table 2). 189 
Similarly, HD patients showed an intake of vitamin K1 significantly lower than controls (Table 3). 190 
This finding was confirmed also when normalized for total energy intake or for body weight (Table 191 
3). We also calculated vitamin K intake after exclusion of the 6 patients on warfarin treatment and 192 
results did not change. 193 
Regarding the recommended intakes, an insufficient intake of vitamin K1 was more common in HD 194 
patients than in control subjects (Table 4). In respect to the AI suggested in 2001 by the National 195 
Research Council, the prevalence of a Vitamin K intake lower than recommended resulted very 196 
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high (89.2%) and roughly double than in controls. According to the Italian RDA value, a low 197 
Vitamin K intake was recorded in 71% of HD patients.  Finally, when a cut-off value of 1 g 198 
Vitamin K1 for kg of body weight is assumed [2], Vitamin K deficiency was observed in 49.5% of 199 
HD patients and in 24.7% of controls (p<0.001).  200 
Table 2 also shows low vitamin D intake for both groups, according to Italian RDA values. 201 
Multivariate logistic model identified Vitamin A and iron as predictors of vitamin K deficiency 202 
according to Italian RDA values (Table 5) and according to AI Dietary Reference Intakes of the 203 
Institute of Medicine (U.S.) Panel on Micronutrients. (Table 6). Comparison between the two 204 
multivariate regression logistic models is shown in Table 7.  205 
 206 
 207 
DISCUSSION 208 
In this study, we assessed the dietary intake of Vitamin K1 in a group of stable patients with CKD 209 
undergoing maintenance HD. As a whole, the proportion of people with insufficient intake of 210 
vitamin K was approximately two fold in HD patients compared to healthy controls. Further 211 
adjustments for energy and body weight did not modify this finding. Our data showed that HD 212 
patients had a remarkable low vitamin K1 intake, since they reported a 2-fold lower median intake 213 
of dietary vitamin K1 than that suggested by RDAs for Italian population. This finding is in 214 
agreement with other observations that patients with chronic kidney disease undergoing HD are at 215 
high risk of vitamin K1 deficiency [14-16]. 216 
To the best of our knowledge, this is the only study available about dietary vitamin K intake in HD 217 
patients in a Mediterranean country, and including a control group. This is a relevant point since the 218 
study by Cranenburg et al. [14] was made in the Netherlands, where dietary habits are quite 219 
different from Mediterranean countries. The type of diet is an important aspect also in patients 220 
undergoing HD, considering that vitamin K is highly dependent from dietary habits. Oriental 221 
countries, for instance, have higher vitamin K intake due to a higher use of some foods, namely 222 
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cabbage kimchi, spinach, spring onions, and soybean oils, lacking in Western countries [22]. Our 223 
findings about HD patients are in agreement with previous reports, suggesting that HD patients 224 
introduce significantly less vitamin K1 than a reference population, independently from dietary 225 
habits [14]. A possible explanation of these findings is that haemodialysis patients on good 226 
nutritional status are advised to limit both sodium and potassium intake, the latter abundant in the 227 
same foods rich in vitamin K1, as green leafy vegetables [23]. This is in agreement with the low 228 
intake of fibres, vitamin A and C, and folate as well. A second possible explanation is that loss of 229 
appetite and food restrictions in the attempt to limit inter-dialysis weight gain are quite common in 230 
this population, affecting the total energy and nutrients intake [24]. In essence, they eat less and this 231 
fact is confirmed by the finding that HD patients had a significantly lower intake of macro- and 232 
micro-nutrients than controls. Although our data may seem underestimated, we believe that data 233 
collection was accurate and these data might reflect the real intake. Accordingly, our data are very 234 
similar to those reported by Martins et al [25] in elderly HD population (namely an energy intake of 235 
18±7 vs. 21±8 kcal/kg/day, and of protein 0.8±0.4 vs. 1.0±0.4 g/kg/day in HD and non-HD days, 236 
respectively). In addition, the Authors reported no differences in energy intake between HD and 237 
non-CKD elderly subjects.  Therefore, the question arises as to whether a low nutrient intake really 238 
occurs in elderly subjects. [26] 239 
No correlation was reported between vitamin K intake and markers of vitamin K status [14]. 240 
However, markedly reduced vitamin K intake was also reported in a cohort of kidney transplant 241 
recipients with a median glomerular filtration rate of 61 ml/min, who did not have significant food 242 
intake limitations [27]. Total vitamin K intake was below the recommended level in 50% of patients 243 
and lower vitamin K intake was associated with less consumption of green vegetables. 244 
Assessing the vitamin K status could be very important in HD patients because it has a key role in 245 
the activation of Gla-proteins involved in bone and tissue calcification. Mineral bone disorders and 246 
vascular calcifications are central issues in the management of chronic kidney disease. Vitamin K 247 
deficiency leads to an impairment in MGP and BGP activation and could indeed contribute to 248 
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worsening the cardiovascular and bone fracture risks in these patients [10]. In a multivariable-249 
adjusted model, we identified Vitamin A (OR 0.996) and iron (OR 0.616) as predictors of vitamin 250 
K deficiency. Interestingly, another fat soluble vitamin, the vitamin A metabolite retinoic acid, 251 
down-regulates MGP gene expression in different rat and human cell lines [28], indicating that diet 252 
can have different effects on vitamin K-dependent proteins activity. Iron intake as predictor of 253 
vitamin K deficiency is a novel finding with no clear explanation, which should be further studied.  254 
The potential benefit of vitamin K supplementation has been shown in studies involving 255 
populations without kidney disease [29-30]. However, these studies have focused on the amount of 256 
vitamin K necessary for an adequate synthesis of blood coagulation factors, but not for the 257 
metabolism of the other vitamin K-dependent proteins, which might be different. Based on the 258 
current knowledge, our study confirms that supplementation is probably needed in HD patients, to 259 
achieve an optimal intake of vitamin K [31]. 260 
The main limitation of the study is that no specific determinations of vitamin K status and of 261 
VKDPs levels or activity (e.g. osteocalcin, MPG, INR) were performed, and that only estimation of 262 
VitK1 intake was reported. Conversely, the strength of our work is the presence of a control group, 263 
and the use of a 7-day dietary recall that was not used in previous investigations. There is great 264 
variability in the content of vitamin K1 in food, so short-term food journals are not suitable to gain 265 
reliable information and appropriate estimations. This is even more relevant in dialysis patients, 266 
whose diet is greatly influenced by dialysis treatments. 267 
It is well known that a potential underestimation of energy and nutrients intake may occur using the 268 
food journal. Even if the food record analysis represent the most valid and simple tool for nutrients 269 
and calories estimation, the occurrence of a conscious or unconscious underreporting is largely 270 
known. We tried to limit this bias collecting an interview at the time of delivery of the 7-day food 271 
journal in order to verify, as described in the method section, the sizes of the portion, the type of 272 
food and any missing data. Furthermore, vitamin K1 and protein intake were normalized to the 273 
energy intake in order to limit the effect of a potential underestimation. Additional methods helping 274 
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in the assessment of energy and proteins intake, such as body weight changes over time before the 275 
dietary questionnaire and nPCR obtained from urea kinetics were not recorded in this study.  276 
The 7-day recall has been demonstrated to be more effective in collecting dietary habits in respect 277 
to other methods (i.e. 3-day recall) [32]. Dietary habits of HD patients may change significantly 278 
from dialysis to non dialysis day and in the weekend days, so the 7-day recall is particularly reliable 279 
to detect the average weekly intake of nutrients. 280 
In conclusion, patients with chronic kidney disease undergoing haemodialysis had a 281 
significantly low intake in vitamin K1, which could contribute to increase the risk of bone fractures 282 
and vascular calcifications. Since the deficiency of vitamin K intake seems to be remarkable, 283 
dietary counselling to HD patients should also address the adequacy of vitamin K dietary intake and 284 
bioavailability. The retrospective nature of our study does not allow to adequately address all the 285 
issues related to vitamin K intake. In particular, data about nPCR and body weight fluctuations 286 
might be of importance to better understand the real dietary intake. In addition, we looked at 287 
vitamin K intake for the possible relationship with fractures and vascular calcifications in dialysis 288 
patients, but these clinical entities are complex and several other nutrients related to bone 289 
metabolism might be involved, such as calcium, phosphorus, vitamin A, vitamin K and vitamin D. 290 
Looking at the relationship between nutrients intake (vitamin K and the other CKD-MBD 291 
related nutrients) and patient outcomes such as fractures and vascular calcification requires a larger 292 
patient population, possibly studied in a prospective study. Also, a randomized trial could allow 293 
evaluating whether diets with higher amounts of vitamin K1 or vitamin K supplementation can 294 
improve clinical outcomes in patients undergoing hemodialysis.  295 
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Table 1. Demographic data of the studied haemodialysis (HD) patients and controls. 390 
 Data are reported as mean ± SD or median (Q1-Q3),  391 
 392 
  393 
 HD patients 
(n=91) 
Controls 
(n=85) 
p-value§ 
Age, years  71 (52, 76) 69 (55, 75) 0,205§ 
Gender – Males, n(%) 55 (60.4) 55 (64.7) 0,559§ 
Weight, kg  70.7±15.6 82.8±14.7 < 0,0001* 
Height 1,66±0,10 1.70±0.9 0,002* 
Body Mass Index, kg/m2  25.3±5.2  28.7±4.5 0,001* 
    
Waist circumference, cm  97.3 ± 13.6  100.3±13.1 0,308* 
Dialysis vintage, months  93 (67 - 121)   
Dialysis technique type, n (%) 
1. Bicarbonate dialysis 
2. Hemofiltration  
3. Hemodiafitration 
4. Acetate free biofiltration 
5. Others 
 
29 (31.9) 
15 (16.5) 
24 (26.4) 
12 (13.2) 
11 (12.1) 
  
Previous transplantation, n (%) 11 (12.1) - - 
    
20 
 
Table 2. Dietary intake of macronutrients, minerals and vitamins in haemodialysis (HD) 394 
patients and in controls. Data are reported as mean ± SD, or median (Q1-Q3).  395 
 HD patients 
(n=91) 
Controls 
(n=85) 
p-value 
    
Total energy, Kcal/d  1442.8 (1292.0, 1442.8 ) 1812 (1515.7, 2136.3 ) <0.0001 
Energy Intake Kcal/kg/d 22.32 ± 6.48 24.80 ± 6.35 0,011 
Total protein, g/d  52.0 (43.9, 67.0 ) 69.4 (58.4, 80.6) <0.0001 
Protein/Weight, g/kg/d 0.82 (0.64, 0.97) 0.88 (0.77, 1.10) 0.013 
Total fat, g/d  50.9 (40.1, 61.6 ) 59.0 (49.7, 73.0) <0.0001 
Carbohydrates, g/d  196.6 (168.7, 236.9 ) 242.4 (203.1, 294.0) <0.0001 
Fiber, g/d 12.0 (9.6, 13.7 ) 19.6 (16.4, 23.3) <0.0001 
    
Ca, mg/d  387.2 (264.9, 583.0 ) 545.2 (418.2, 636.9) <0.0001 
P, mg/d  755.9 (622.5, 922.5 ) 1005.2 (826.1, 1179.2) <0.0001 
Fe, mg/d  6.7 (5.6, 8.6) 8.8 (7.7, 10.7) <0.0001 
Na mg/d  1206.3 (887.5, 1630.3) 1492.2 (938.7, 1833.4) 0.003 
K, mg/d  1556.4 (1247.4, 2037.1 ) 2514.5 (2158.8, 3191.1) <0.0001 
Zn, mg/d  6.8 (5.3, 8.2) 8.0 (6.4, 10.5) <0.0001 
Cu, mg/d  0.9 (0.6, 1.3) 1.2 (1.1, 2.3) <0.0001 
Mg, mg/d  152.6 (120.7, 190.4) 200.1 (172.0, 267.6) <0.0001 
    
Vit A, mcg/d  306.0 (130.6, 306.0) 460.8 (286.0, 566.7) <0.0001 
Vit B1, mg/d  0.7 (0.58, 0.88) 0.84 (0.7, 1.1) <0.0001 
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  396 
Vit B2, mg/d  0.9 (0.7, 1.2) 1.3 (1.0, 1.4) <0.0001 
Vit C, mg/d  47.3 (29.4, 67.8) 67.5 (52.4, 92.7) <0.0001 
Vit D, g/d 1.1 (0.8, 1.1) 1.6 (0.5, 2.4) 0.029 
Vit E, g/d  7.4 (5.5, 9.8) 11.5 (10.3, 13.7) <0.0001 
Folates, g/d  77.4 (57.9, 118.9) 141.2 (80.7, 181.0) <0.0001 
PP, mg/d  10.2 (7.3, 12.9) 12.4 (8.9, 16.7) <0.0001 
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Table 3. Dietary intake of Vitamin K1  in haemodialysis (HD)  patients and in controls, as 397 
average total daily intake, or normalized per body weight and per 1000 Kcal energy intake  398 
 Data are reported as mean ± SD, or median (Q1-Q3). 399 
 400 
  401 
 HD patients 
(n=91) 
Controls 
(n=85) 
p-value 
 
Vitamin K1, g /d  71.6 (35.5, 117.1) 129.2 (61.5, 380.5) 
 
<0.0001 
Vitamin K1  g /kg b.w. 1.00 (0.50, 2.22) 1.84 (1.00, 4.83) <0.0001 
Vitamin K1 g / 1000 Kcal  46.8 (25.1, 85.9) 88.9 (31.0, 210.2) <0.0001 
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Table 4. Vitamin K intake in hemodialysis (HD) patients and in controls, according to 402 
Recommended Dietary Allowance,  Italy and AI  Dietary Reference Intakes of the Institute of 403 
Medicine (U.S.). Panel on Micronutrients  404 
  405 
 HD patients 
(n=91) 
Controls 
(n=85) 
p-value 
Recommended Dietary Allowance, 
Italy. 2012. [9] 
   
< 60 yrs old:  < 140 g/die, n (%) 28 (30.8) 16 (18.8) < 0.0001 
> 60 yrs old:  < 170 g/die, n (%) 44 (48.4) 22 (25.9)  
Total, n (%) 72 (89.2) 38 (44.7)  
    
AI Dietary Reference Intakes of the  
Institute of Medicine (U.S.). Panel 
on Micronutrients, 2001. [8]  
   
Men: < 120 µg/day, n (%) 41 (45.1) 27 (31.8) < 0.0001 
Women: < 90 µg/day, n (%)   24 (26.4) 6 (7.1)  
Total, n (%) 65 (71.5) 33 (38.8)  
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 Table 5. Logistic regression model for identifying predictors of vitamin K deficiency 406 
according to Italian Recommended Dietary Allowance RDA values. Stepwise selection method 407 
among significant variables (P < 0.10) in the univariate model. 408 
Variable Unadjusted models Multivariable-adjusted models 
OR (95% CI) P-Value OR (95% CI) P-Value 
Vit A, g /d 0.994 (0.991, 0.997) < 0.001 0.996 (0.992, 0.999) 0.022 
Vit C, mg/d 0.977 (0.964, 0.991) < 0.001 0.999 (0.971, 1.009) 0.305 
Folates, g /d 0.984 (0.974, 0.995)  0.005 0.991 (0.979, 1.004) 0.193 
Ca, mg/d 0.996 (0.993, 0.999) 0.004 0.998 (0.993, 1.002) 0.288 
Fe, mg/d 0.647 (0.503, 0.831) 0.005 0.616 (0.421, 0.901) 0.013 
  409 
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Table 6. Logistic regression model for identifying predictors of vitamin K deficiency 410 
according to AI Dietary Reference Intakes of the Institute of Medicine (U.S.) Panel on 411 
Micronutrients. Stepwise selection method among significant variables (P < 0.10) in the 412 
univariate model. 413 
 414 
Variable Unadjusted models Multivariable-adjusted models 
OR (95% CI) P-Value OR (95% CI) P-Value 
Age, years 0.97 (0.937, 1.005) 0.089 0.993 (0.939, 1.051) 0,814 
Cholesterol, mg/d 0.994 (0.988, 0.999) 0.032 1.003 (0.993, 1.006) 0,577 
Ca, mg/d 0.997 (0.994, 1) 0.027 0.999 (0.995, 1.003) 0,507 
Fe, mg/d 0.737 (0.599, 0.906) 0.004 0.661 (0.472, 0.927) 0,016 
Vitamin A, g /d 0.994 (0.991, 0.997) < 0.001 0.995 (0.991, 1) 0,032 
Vitamin C, mg/d 0.978 (0.965, 0.991) 0.001 0.993 (0.974, 1.013) 0,486 
Vitamin E g/d  0.856 (0.762, 0.961) 0.009 1.05 (0.867, 1.271) 0,618 
Folates, g /d 0.985 (0.975, 0.995) 0.004 0.987 (0.97, 1.004) 0,136 
  415 
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Table 7. Comparison between the two multivariate regression logistic models. 416 
Variable LARN AI Dietary 
OR (95% CI) P-Value OR (95% CI) P-Value 
Age, years / / 0.993 (0.939, 1.051) 0,814 
Vit A, g /d 0.996 (0.992, 0.999) 0.022 0.995 (0.991, 1) 0,032 
Vit C, mg/d 0.999 (0.971, 1.009) 0.305 0.993 (0.974, 1.013) 0,486 
Vit E, g /d / / 1.05 (0.867, 1.271) 0,618 
Folates, g /d 0.991 (0.979, 1.004)  0.193 1.026 (0.963, 1.094) 0,426 
Ca, mg/d 0.998 (0.993, 1.002) 0.288 0.999 (0.995, 1.003) 0,507 
Fe, mg/d 0.616 (0.421, 0.901) 0.013 0.661 (0.472, 0.927) 0,016 
Cholesterol, mg/d / / 1.003 (0.993, 1.006) 0,577 
 417 
